Skip to main content
IMNM logo
IMNM
(NASDAQ)
Immunome, Inc.
$21.84-- (--)
Loading... - Market loading

Immunome (IMNM) Stock Price & Financial Analysis

Immunome Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$21.41 - $22.62
52-Week High$27.65
52-Week Low$5.15
Open$21.64
Volume1.50M
Average Volume (3M)1.50M
Market Cap1.91B
Shares Outstanding87.35M
Price to Sales (P/S)282.53
Price to Book (P/B)3.09
EV/EBITDA-6.21
Revenue (TTM)6.94M
Net Income (TTM)-212.39M
Free Cash Flow (TTM)-206.85M
EPS (TTM)$-2.43
Profit Margin-3059.99%
Operating Margin-3084.76%
Return on Equity (ROE)-33.48%
Debt to Equity0.01
50-Day MA$22.55
200-Day MA$16.15
52-Week Change258.63%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immunome

What is the current stock price for IMNM?

As of the latest trading session, IMNM stock trades at $21.84. The 52-week range is $5.15–$27.65, with a day range of $21.41–$22.62.

What is the P/E ratio for IMNM?

The P/E ratio (Price-to-Earnings) for IMNM is shown in the Key Statistics section. This valuation metric helps compare Immunome, Inc. to industry peers.

Does IMNM pay dividends?

Immunome does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMNM?

Based on 9 analysts, the consensus for IMNM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMNM?

Immunome's market capitalization is $1.91B, classifying it as a small-cap company. Immunome operates in the Healthcare sector within the Biotechnology industry.